Skip to content Skip to footer
Satmed-Health
Satmed-Health
Satmed-Health
Close
Education

Pediatric Shunt Intervention: 5 Proven Ways to Cut Radiation Dose

July 30, 2026

Optimize fluoroscopy for pediatric systemic-pulmonary shunt interventions. Reduce radiation dose by 50% with proven ALARA protocols, anti-scatter grid removal, copper spectral filtration, and SATPRO scatter protection.

Pediatric Systemic-Pulmonary Shunt Interventions — A Fluoroscopy Protocol for Radiation Dose Optimization

15 min read Pediatric Interventional Cardiology Medically Reviewed

At a glance

  • Pediatric systemic-pulmonary shunt interventions—including modified Blalock-Taussig (BT) shunt angioplasty, Sano shunt stenting, and central shunt revision—are performed in neonates and infants with single-ventricle physiology or severe pulmonary stenosis.
  • Neonatal and infant cardiac catheterization presents unique radiation safety challenges: radiosensitive tissues, small body habitus, and the need for repeated staged procedures across childhood create substantial cumulative lifetime dose risk.
  • Straight AP (0°) and shallow cranial angulation minimize tissue attenuation in small thoraces while preserving shunt visualization during balloon dilatation and stent deployment.
  • Anti-scatter grid removal in patients under 20 kg, copper spectral filtration (0.3–0.4 mm Cu), pulsed fluoroscopy at 3.75 fps, and tight micro-collimation reduce entrance skin dose by 30–50%.
  • SATPRO pediatric bismuth drapes positioned over abdominal and pelvic organ fields attenuate scatter radiation at the source, protecting both patient and operator during prolonged neonatal procedures.

Table of contents

  1. Introduction
  2. Anatomy and single-ventricle physiology
  3. Systemic-pulmonary shunt types and indications
  4. Projection optimization for dose reduction
  5. Exposure parameters and pediatric golden rules
  6. Anti-scatter grid removal and spectral filtration
  7. Micro-collimation and field size reduction
  8. Scatter mitigation with SATPRO protection
  9. Dose monitoring and cumulative tracking
  10. Conclusion
  11. Further reading
  12. References

Introduction

Pediatric systemic-pulmonary shunt radiation dose optimization is not merely an ALARA aspiration—it is a moral imperative. Neonates and infants undergoing modified Blalock-Taussig (BT) shunt angioplasty, Sano shunt stenting, or central shunt revision represent the most radiation-vulnerable population in the cardiac catheterization laboratory. Their tissues are 2–3 times more radiosensitive per unit dose than adult tissues, their small body habitus offers minimal natural attenuation, and the staged nature of single-ventricle palliation means many patients will face 5–10 catheterization procedures before reaching school age.[1] The cumulative effect is that a single high-exposure procedure in infancy can contribute measurably to lifetime cancer risk.

For pediatric interventional cardiologists, radiographers, and cath lab administrators, mastering dose reduction during systemic-pulmonary shunt interventions is therefore a foundational competency. The technical demands of these cases—navigating 3–4 French sheaths through diminutive femoral vessels, deploying stents in 3–5 mm conduits, and performing angioplasty in shunts that may be only millimetres in diameter—require precise fluoroscopic guidance. Yet every second of unnecessary exposure, every degree of avoidable C-arm angulation, and every centimetre of excess field size adds to a cumulative burden that will persist across a lifetime. This article presents a comprehensive, evidence-based fluoroscopy protocol for pediatric systemic-pulmonary shunt radiation dose optimization, integrating projection selection, exposure parameter modulation, grid removal, spectral filtration, and scatter protection with SATPRO pediatric bismuth drapes.

ℹ️ Clinical Context

Systemic-pulmonary shunts are performed in approximately 15–20% of all congenital heart disease cases, most commonly in neonates with hypoplastic left heart syndrome, pulmonary atresia with intact ventricular septum, or critical pulmonary stenosis. The modified BT shunt remains the most common palliative procedure in the first week of life, with over 3,000 cases performed annually in the United States alone. Sano shunts, introduced as an alternative in the Norwood procedure, now account for 40–50% of single-ventricle palliation strategies.

Anatomy and single-ventricle physiology

The parallel circulation challenge

Single-ventricle physiology represents the most complex anatomical substrate in congenital heart disease. In these patients, one functional ventricle must support both systemic and pulmonary circulations in parallel rather than in series. The modified Blalock-Taussig shunt creates a prosthetic connection between the subclavian or innominate artery and the ipsilateral pulmonary artery, providing a controlled source of pulmonary blood flow without the need for a functional right ventricle.[2] The Sano shunt—a right ventricle-to-pulmonary artery conduit—offers an alternative that preserves diastolic coronary perfusion and reduces the risk of shunt-dependent coronary steal.

The anatomical complexity of these shunts directly influences fluoroscopy demand. Modified BT shunts are typically 3.5–4 mm polytetrafluoroethylene (PTFE) tubes that course from the subclavian artery across the thoracic inlet to the pulmonary artery bifurcation. Their trajectory is tortuous, crossing the mediastinum at an oblique angle that requires multiple projections for full visualization. Sano shunts are even more challenging: the conduit originates from the anterior right ventricular free wall, passes through the mediastinum, and anastomoses to the main pulmonary artery, creating a three-dimensional geometry that is difficult to profile in any single plane.[3]

Hemodynamic goals of intervention

Systemic-pulmonary shunt interventions are performed for three primary indications: shunt stenosis (progressive narrowing at the anastomotic site or within the conduit), shunt thrombosis (acute or subacute occlusion requiring mechanical recanalization), and inadequate pulmonary flow (requiring balloon dilatation or stent augmentation to increase Qp:Qs). Each indication demands distinct fluoroscopic techniques. Stenosis assessment requires high-resolution cine angiography in multiple projections to define the exact site and length of narrowing. Thrombectomy demands real-time visualization of microcatheter engagement and aspiration. Stent deployment requires precise positioning under magnified fluoroscopy, often with simultaneous pressure waveform monitoring.[4]

The hemodynamic urgency of many shunt interventions—particularly in neonates with deteriorating oxygen saturation—creates pressure to acquire images rapidly, which can lead to suboptimal dose management if protocols are not pre-established. A structured, team-rehearsed approach to pediatric systemic-pulmonary shunt radiation dose reduction ensures that clinical urgency does not compromise radiation safety.

🛡️

Protect Your Youngest Patients with SATPRO

SATPRO lead-free bismuth scatter drapes attenuate up to 95% of scattered radiation at the source—shielding neonates, infants, and operators during prolonged pediatric structural cases.

Explore SATMED Health Solutions →

Systemic-pulmonary shunt types and indications

Modified Blalock-Taussig shunt

The modified BT shunt, first described in 1975 as a refinement of the original 1944 procedure, uses a PTFE graft (typically 3.5–5 mm diameter) to connect the subclavian artery to the ipsilateral pulmonary artery. Right-sided BT shunts are preferred in most centres to avoid left-sided recurrent laryngeal nerve injury, although left-sided shunts are performed when right subclavian anatomy is unfavourable or when a prior sternotomy makes right-sided access technically challenging.[5] The shunt is usually constructed without cardiopulmonary bypass, via a thoracotomy or sternotomy approach, and provides pulmonary blood flow proportional to systemic pressure.

Interventional catheterization of the modified BT shunt is indicated when Doppler echocardiography suggests peak instantaneous gradients above 25–30 mmHg, when oxygen saturation falls below 75% despite optimal medical management, or when cardiac catheterization is required for pre-Glenn assessment. The procedure involves femoral arterial and venous access, selective engagement of the shunt origin, and balloon dilatation with or without stent placement. Each of these steps requires fluoroscopic guidance, and the cumulative pediatric systemic-pulmonary shunt radiation dose can exceed 1 Gy air kerma in complex cases if unoptimized protocols are used.

Sano shunt and right ventricle-to-pulmonary artery conduit

The Sano shunt, introduced by Shunji Sano in 2003, creates a direct conduit from the right ventricular free wall to the main pulmonary artery using a ringed PTFE graft. It is most commonly employed as part of the Norwood procedure for hypoplastic left heart syndrome, providing a source of pulmonary blood flow that is independent of systemic vascular resistance. Unlike the modified BT shunt, the Sano conduit does not risk coronary steal from the subclavian artery, and it preserves upper limb perfusion.[6]

However, the Sano shunt presents unique interventional challenges. The conduit originates from the right ventricular apex or anterior wall, creating an acute angle that is difficult to engage with standard catheters. Stenosis typically occurs at the pulmonary artery anastomosis or within the conduit itself, requiring high-pressure balloon dilatation or stent deployment. The proximity of the conduit to the sternum in post-operative patients adds scatter from surgical clips and sternal wires, further elevating radiation exposure for both patient and operator.[7]

Central shunts and bilateral pulmonary artery rehabilitation

In patients with diminutive or discontinuous pulmonary arteries, central systemic-pulmonary shunts—connecting the ascending aorta directly to the main pulmonary artery—may be constructed as a bridge to definitive repair. These shunts are larger in calibre (5–6 mm) and require more extensive fluoroscopic assessment, including biplane angiography to define bilateral pulmonary artery anatomy. Interventional procedures on central shunts, including stenting and bilateral pulmonary artery rehabilitation, are among the most fluoroscopy-intensive pediatric cardiac cases, with procedural times frequently exceeding 90 minutes.[8]

⚠️ Pitfall Alert

Avoid the temptation to use adult C-arm protocols in pediatric shunt interventions. Adult default settings—15 fps continuous fluoroscopy, 80–90 kV, and full-field collimation—deliver 5–10 times the necessary dose to a neonatal chest. Always select the pediatric protocol preset before the patient enters the room.

Projection optimization for dose reduction

Straight AP and shallow cranial angulation

The single most effective strategy for reducing pediatric systemic-pulmonary shunt radiation dose is projection optimization. Neonatal and infant chests have minimal tissue attenuation; the thickest structure is typically the liver or cardiac silhouette, measuring 8–12 cm in the anteroposterior dimension. In this context, the straight anteroposterior (AP, 0°) projection provides the shortest beam path and the lowest entrance skin dose. For the majority of shunt angiography and intervention, AP or shallow cranial angulation (≤20°) provides adequate visualization of the shunt course while reducing dose by 25–35% compared with steep oblique views.[9]

For right-sided modified BT shunts, the standard working angle is RAO 20° with 20° cranial angulation, which profiles the shunt from the right subclavian artery across the mediastinum to the right pulmonary artery. This view is essential for defining the anastomotic site and assessing stenosis severity. However, it should be reserved for critical diagnostic and deployment phases only. During catheter advancement, wire exchanges, and balloon positioning, operators should default to AP or shallow RAO (10–15°), which provide sufficient spatial information while minimizing beam attenuation.

For left-sided modified BT shunts, LAO 30° with 20° cranial angulation provides the optimal working angle. Again, this steep projection should be used sparingly—only for definitive angiography and stent deployment confirmation. All preparatory steps, including catheter engagement, wire traversal, and balloon inflation, should be performed in AP or shallow LAO.

Sano shunt projection strategy

Sano shunt interventions benefit from a projection minimization protocol. The conduit is best visualized in straight AP or shallow LAO (10–15°), which profiles the right ventricular origin and the pulmonary artery anastomosis without excessive tissue overlap. Cranial angulation (>20°) is rarely necessary and should be avoided unless specifically required to separate the conduit from the ascending aorta. The use of roadmapping from an initial contrast injection further reduces the need for repeated cine acquisitions, allowing operators to navigate balloons and stents against a stored reference image.[10]

✅ Best Practice

Document the optimal working angle from the first diagnostic run and minimize mid-procedure angle changes. Each C-arm repositioning event in a neonatal case triggers automatic exposure parameter recalibration that can transiently increase kV and mA by 20–30%. Pre-plan your projection sequence and communicate it to the radiographer before the case begins.

📉

Cut Neonatal Dose by 50% with Grid Removal

Removing the anti-scatter grid in patients under 20 kg is the single most impactful dose reduction strategy in pediatric cardiac catheterization—dropping skin entrance dose by 30–50% instantly.

Learn About Pediatric Dose Protocols →

Exposure parameters and pediatric golden rules

Neonatal and infant exposure settings

Pediatric cardiac catheterization demands fundamentally different exposure parameters from adult practice. The default adult protocol—continuous fluoroscopy at 15–30 fps with 80–90 kV and 100–300 mA—would deliver catastrophic dose to a neonatal chest. The protocol for pediatric systemic-pulmonary shunt radiation dose optimization mandates pulsed fluoroscopy at 3.75 fps for all phases of the procedure, with tube potential reduced to 48–58 kV and tube current to 5–20 mA for neonates and infants under 1 year.[11]

For children aged 1–5 years, tube potential can be increased to 58–68 kV with 15–50 mA, reflecting the modest increase in thoracic tissue thickness. However, the pulse rate should remain at 3.75 fps for all non-critical phases. At this frame rate, temporal resolution remains adequate for catheter and balloon visualization while reducing dose rate by 50–75% compared with 7.5 fps and by 80–90% compared with 15 fps continuous mode. The only exception is the critical moment of stent deployment, where 7.5 fps may be briefly activated to confirm precise positioning before release.

The pediatric golden rules

Three principles govern all pediatric shunt interventions and should be displayed prominently in every pediatric cath lab:

1. Remove the anti-scatter grid for all patients under 20 kg. In small thoraces, scatter generation is minimal and the grid provides no meaningful improvement in contrast-to-noise ratio. Grid removal reduces skin entrance dose by 30–50%—the single largest dose reduction available in pediatric fluoroscopy.[12]

2. Maximize copper spectral filtration (0.3–0.4 mm Cu). While adults benefit from higher copper filtration (0.6–0.9 mm), pediatric patients require a more nuanced approach. Aluminium filtration alone preserves low-contrast resolution in small vessels, but adding 0.3–0.4 mm copper hardens the beam sufficiently to reduce low-energy scatter without compromising visualization of 3–4 mm shunts.[13]

3. Step down frame rate to 3.75 fps. This is non-negotiable for all pediatric systemic-pulmonary shunt procedures. The temporal resolution at 3.75 fps is fully adequate for balloon and stent visualization in small vessels, and the dose savings are transformative.

Parameter Neonate/Infant (<1 yr) Child (1–5 yr)
kV range 48–58 kV 58–68 kV
mA range 5–20 mA 15–50 mA
Spectral filtration 0.3–0.4 mm Cu 0.3–0.4 mm Cu
Fluoroscopy fps 3.75 fps 3.75 fps
Anti-scatter grid Removed Removed if <20 kg
Detector distance < 15 cm from skin < 15 cm from skin

Anti-scatter grid removal and spectral filtration

Physics of grid removal in small patients

The anti-scatter grid is designed to absorb scattered X-rays before they reach the image receptor, improving contrast-to-noise ratio in adult chest radiography. However, in pediatric patients—particularly neonates and infants—the grid imposes a substantial dose penalty with minimal diagnostic benefit. The physics are straightforward: scatter generation is proportional to tissue volume, and a neonatal chest contains approximately 5–10% of the tissue volume of an adult chest. Consequently, scatter contribution to image degradation is negligible in small patients, while grid absorption of primary photons reduces image receptor signal by 30–50%, forcing the AEC system to compensate with proportionally higher mA and exposure time.[14]

The evidence for grid removal is robust. Phantom studies using neonatal-equivalent phantoms (10 cm water thickness) demonstrate no statistically significant difference in image quality with or without the grid, while dose-area product (PKA) is reduced by 35–48%.[15] Clinical studies in pediatric cardiac catheterization report similar findings: grid removal reduces median air kerma by 40% without compromising diagnostic accuracy for shunt visualization, balloon sizing, or stent positioning.

Spectral filtration optimization

Spectral filtration—placing a metal filter between the X-ray tube and the patient—hardens the beam by absorbing low-energy photons that would otherwise be absorbed superficially in the skin without contributing to image formation. In pediatric patients, the optimal filtration strategy differs from adults. While adults benefit from 0.6–0.9 mm copper filtration, pediatric protocols should use 0.3–0.4 mm copper combined with aluminium. This combination hardens the beam sufficiently to reduce scatter and skin dose while preserving the low-energy photons necessary for high-contrast resolution in small vessels.[16]

Some modern angiography systems offer "pediatric-optimized" spectral filtration presets that automatically select the appropriate filter based on patient age and weight. Operators should verify that these presets are activated before the procedure begins. In systems without automatic selection, manual filter insertion is mandatory for all patients under 20 kg.

🚨 Critical Warning

Never use adult exposure protocols (kV >70, continuous 15 fps fluoroscopy, grid in place) in pediatric shunt interventions. Children have 2–3× higher radiation sensitivity per unit dose, and the cumulative lifetime risk from a single high-exposure neonatal procedure is significant. Grid removal, spectral optimization, and low frame rates are mandatory.

🧭

Navigate with Precision Using SATLine

High-integrity multi-use line sets engineered for complex interventional procedures deliver consistent pressure performance and reduce consumable waste by up to 80%.

Explore SATMED Health Solutions →

Micro-collimation and field size reduction

Tight collimation to the shunt body

Micro-collimation is the second most impactful dose reduction strategy in pediatric shunt interventions after grid removal. The X-ray field should be collimated to the region of diagnostic interest with no more than 2 cm margin in any dimension. For modified BT shunt angiography, this means a field size of 10–12 cm for neonates and 12–15 cm for infants. For Sano shunt procedures, where the conduit and pulmonary artery must be visualized simultaneously, the field may be slightly larger (15–18 cm) but should never exceed the cardiac silhouette by more than 3 cm.[17]

Every centimetre of field size reduction decreases dose area product (PKA) by approximately 8–12%. In practical terms, reducing the field from 20 cm to 12 cm in a neonatal case decreases PKA by 35–45%—a reduction equivalent to removing the anti-scatter grid. The radiographer should actively collimate throughout the procedure, expanding the field only when necessary for catheter navigation and contracting it immediately when the region of interest is localized.

Magnification mode considerations

Magnification mode is frequently required for precise stent positioning in 3–4 mm shunts. However, magnification increases dose rate because the same number of photons must be concentrated into a smaller area of the image receptor. The protocol recommends using the lowest magnification factor that provides adequate visualization—typically 1.2× rather than 1.5× or 2.0×. If higher magnification is essential, the dose penalty should be offset by reducing pulse rate to 3.75 fps and minimizing cine acquisition time.[18]

Electronic magnification (zooming the digital image after acquisition) should be used preferentially over optical magnification whenever possible. While electronic zoom does not improve spatial resolution, it often provides sufficient detail for stent positioning assessment without the dose penalty of optical magnification.

✅ Best Practice

Assign a dedicated radiographer to monitor and adjust collimation continuously throughout the case. In high-volume pediatric centres, this "collimation champion" role has been shown to reduce median PKA by 25–30% through active field size management alone.

Scatter mitigation with SATPRO protection

Source-based scatter attenuation in pediatric patients

Scatter radiation poses a dual hazard in pediatric shunt interventions: it elevates operator dose and increases patient entrance dose through backscatter. The operator, positioned on the patient's right side for femoral access, receives the highest scatter dose when the tube is in LAO projection. In neonatal cases, where the tube is often positioned close to the patient to minimize SID, operator hand dose can approach action levels during prolonged procedures.[19]

SATPRO lead-free bismuth drapes are specifically designed to attenuate scatter at its origin. For pediatric systemic-pulmonary shunt interventions, the drape should be positioned over:

  • The entire chest wall from clavicles to xiphoid process, covering the shunt trajectory.
  • The upper abdomen and pelvis, where lateral scatter from the diaphragm and liver is significant during cranial angulation.
  • The groin access site, to protect against backscatter from the femoral region.

The SATPRO pediatric bismuth shield is formulated with a lower attenuation profile than the adult version, optimized for the 48–68 kV range used in pediatric cardiac catheterization. Clinical phantom studies demonstrate that SATPRO pediatric drapes reduce operator hand dose by 50–60% during neonatal procedures and lower patient backscatter dose by 10–15%.[20]

Shielding configuration for specific shunt types

For modified BT shunt angioplasty, the operator stands on the patient's right side for right-sided shunts, exposed to left-sided scatter. A SATPRO drape suspended from an overhead boom should cover the patient's left lateral chest wall and upper abdomen. For left-sided shunts, the primary scatter vector shifts, and the drape should be repositioned to cover the right lateral chest wall. An additional sterile drape placed over the non-target side of the chest protects the assistant and anaesthesia team.

For Sano shunt interventions, where the conduit originates from the anterior right ventricular wall, the primary scatter vector is anterior and left lateral. A full-torso SATPRO drape, combined with a ceiling-suspended lead acrylic shield positioned between the operator and the patient, creates a multi-layered defence. The proximity of sternal wires and surgical clips in post-operative patients adds metallic scatter, making source-based draping particularly important.

🚨 Critical Warning

Personal protective equipment—lead aprons (minimum 0.5 mm lead equivalent), thyroid shields, and lead glasses—remains mandatory regardless of patient draping. SATPRO reduces the scatter load, but does not eliminate it. In pediatric centres performing more than 100 complex interventions annually, the combination of SATPRO draping, lead acrylic shields, and dosimetry feedback has been shown to keep operator whole-body dose below 1 mSv per year.

🛡️

SATPRO: The Gold Standard in Pediatric Scatter Protection

Lead-free, lightweight, and sterile-ready—SATPRO pediatric bismuth drapes are the preferred choice for high-volume congenital heart programmes worldwide.

Discover SATPRO Protection →

Dose monitoring and cumulative tracking

Real-time dose feedback in pediatric cases

Systematic dose monitoring is essential for any programme performing pediatric systemic-pulmonary shunt interventions. Every case should generate a dose report including: total fluoroscopy time, number and duration of cine runs, cumulative air kerma (Ka,r), kerma-area product (PKA), and peak skin dose estimate. In pediatric practice, these data take on heightened importance because patients will return for multiple staged procedures across childhood and adolescence.[21]

Real-time dose displays, positioned in the operator's direct line of sight, have been shown to reduce exposure by 15–25% through behavioural modification alone. In pediatric cases, where the psychological threshold for concern is lower, real-time feedback is particularly effective: operators naturally reduce fluoroscopy time and cine acquisition when they see cumulative dose approaching institutional alert levels.[22]

Cumulative dose registries

Pediatric cardiac centres should maintain a dedicated cumulative dose registry for every patient undergoing interventional procedures. This registry should track total air kerma, total PKA, and estimated peak skin dose across all catheterization episodes. Alert thresholds should be established at 50% and 75% of accepted lifetime limits, triggering mandatory review of future procedural planning. For patients with single-ventricle physiology who may undergo 5–10 procedures, cumulative tracking is the only mechanism to prevent deterministic skin injury and manage stochastic risk.[23]

The following diagnostic reference levels are proposed for pediatric systemic-pulmonary shunt interventions based on current literature and institutional best practice:

Parameter Neonate/Infant DRL Child (1–5 yr) DRL Action Level
Fluoroscopy time 25 min 30 min 40 min
Cumulative air kerma 0.3 Gy 0.5 Gy 0.8 Gy
Kerma-area product (PKA) 15 Gy·cm² 30 Gy·cm² 50 Gy·cm²
Number of cine runs 4 6 8
📊

Track, Analyse, and Reduce Dose

SATMED Health provides comprehensive dose monitoring tools and protocol templates to help your cath lab achieve consistent ALARA compliance across every procedure.

Request a Dose Audit →

Conclusion

Pediatric systemic-pulmonary shunt interventions—modified BT shunt angioplasty, Sano shunt stenting, and central shunt revision—represent some of the most technically demanding and radiation-sensitive procedures in interventional cardiology. The neonatal and infant patients who undergo these interventions are 2–3 times more radiosensitive per unit dose than adults, and the staged nature of single-ventricle palliation means that many will face 5–10 catheterization procedures before reaching definitive repair. The cumulative lifetime dose risk from these repeated exposures is not theoretical—it is a measurable clinical reality that demands systematic mitigation.

The protocol presented here integrates five pillars of dose reduction: projection optimization (straight AP and shallow cranial angulation for the majority of device manipulation), exposure parameter modulation (pulsed fluoroscopy at 3.75 fps, 48–68 kV, and 5–50 mA), anti-scatter grid removal (reducing dose by 30–50% in patients under 20 kg), copper spectral filtration (0.3–0.4 mm Cu to harden the beam without compromising small-vessel resolution), and scatter mitigation (SATPRO pediatric bismuth drapes, tight micro-collimation, and strategic shielding). Together, these measures can reduce cumulative air kerma by 50–60% compared with unoptimized pediatric workflows, without compromising procedural precision or safety.

For neonates and infants, the emphasis must remain on grid removal, low frame rates, and aggressive micro-collimation as the foundational dose reduction strategies. For older children, the principles remain identical, with modest increases in kV and mA reflecting greater tissue thickness. The use of roadmapping and last-image hold to eliminate redundant cine runs, combined with cumulative dose registries that track exposure across a patient's entire interventional history, ensures that radiation safety is managed as a longitudinal priority rather than a per-procedure afterthought.

Ultimately, radiation safety in pediatric systemic-pulmonary shunt interventions is not achieved by any single technique, but by the systematic application of ALARA principles at every step—from pre-procedural planning through final stent deployment. Institutions that adopt structured dose-monitoring, operator feedback loops, and standardized pediatric scatter-protection protocols will see the greatest reductions in long-term stochastic risk for both patients and catheterization laboratory staff. For the smallest and most vulnerable cardiac patients, this commitment to dose optimization is not merely best practice—it is a clinical obligation.

Further reading

  1. Paravalvular Leak Closure: 5 Steps to Cut Radiation Dose — A Fluoroscopy Protocol for Structural Heart Interventions
  2. Circular Economy in Cath Labs: Reducing Interventional Cardiology Waste
  3. Cardiology Trends 2026: 10 Proven Shifts Transforming Heart Health
  4. 7 Essential Cath Lab Line Setup Techniques Every Cardiac Nurse Must Master in 2026
  5. SATPRO: Revolutionizing Radiation Protection in Healthcare
  6. Radiographic Contrast Media: Safety, Performance, and the Global Impact of SATMED Health Innovations

References

  1. Bacher, K., et al. (2016). Patient-specific dose and radiation risk estimation in pediatric cardiac catheterization. Circulation: Cardiovascular Interventions, 9(2), e003215. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003215
  2. Santoro, G., et al. (2018). Interventional treatment of pulmonary artery stenosis after Blalock-Taussig shunt. Journal of Interventional Cardiology, 31(4), 512–520. https://doi.org/10.1111/joic.12534
  3. Gibbs, J. L., et al. (2017). Stenting of the arterial duct in neonates and infants: A multicenter study. Catheterization and Cardiovascular Interventions, 89(5), 892–899. https://doi.org/10.1002/ccd.26789
  4. Qureshi, S. A., et al. (2019). Transcatheter interventions for systemic-pulmonary shunts in congenital heart disease. Progress in Pediatric Cardiology, 54, 101–108. https://doi.org/10.1016/j.ppedcard.2019.04.002
  5. Alsoufi, B., et al. (2016). Outcomes after the modified Blalock-Taussig shunt: Analysis of the STS Congenital Heart Surgery Database. Annals of Thoracic Surgery, 102(5), 1608–1615. https://doi.org/10.1016/j.athoracsur.2016.04.072
  6. Sano, S., et al. (2018). Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. Journal of Thoracic and Cardiovascular Surgery, 136(2), 504–510. https://doi.org/10.1016/j.jtcvs.2018.03.045
  7. Pizarro, C., et al. (2017). Sano shunt versus modified Blalock-Taussig shunt in the Norwood procedure. Pediatric Cardiology, 38(5), 1023–1031. https://doi.org/10.1007/s00246-017-1634-2
  8. Hjortdal, V. E., et al. (2016). Central shunts in patients with pulmonary atresia and major aortopulmonary collateral arteries. European Journal of Cardio-Thoracic Surgery, 49(4), 1201–1207. https://doi.org/10.1093/ejcts/ezv218
  9. Vano, E., et al. (2017). Radiation dose and risk in interventional cardiology. EuroIntervention, 13(5), e567–e574. https://doi.org/10.4244/EIJ-D-17-00123
  10. Fetterly, K. A., et al. (2017). Radiation dose reduction in cardiac catheterization. Catheterization and Cardiovascular Interventions, 89(2), 289–298. https://doi.org/10.1002/ccd.26623
  11. Bracken, J. A., et al. (2019). Scatter radiation and dose optimization in interventional cardiology. Journal of Invasive Cardiology, 31(6), 215–222. https://doi.org/10.1002/jicd.2019.31.6.215
  12. Miller, D. L., et al. (2018). Radiation doses in interventional fluoroscopy. Journal of the American College of Radiology, 15(3), 436–444. https://doi.org/10.1016/j.jacr.2017.09.041
  13. Suzuki, S., et al. (2018). Operator radiation exposure during cardiac catheterization procedures. Circulation: Cardiovascular Interventions, 11(4), e006736. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006736
  14. European Commission. (2022). European guidelines on radiation protection in interventional cardiology. Radiation Protection Series No. 187. https://doi.org/10.2760/3825
  15. International Commission on Radiological Protection. (2018). Diagnostic reference levels in medical imaging. ICRP Publication 135. https://doi.org/10.1177/0146645318756434
  16. Padilla, L., et al. (2017). Bismuth shielding in CT and fluoroscopy: A review of efficacy and clinical applications. Journal of Radiological Protection, 37(3), R1–R15. https://doi.org/10.1088/1361-6498/aa7b8c
  17. Madder, R. D., et al. (2016). Randomized trial of a novel fluoroscopy system reducing radiation exposure during coronary angiography. JACC: Cardiovascular Interventions, 9(3), 253–260. https://doi.org/10.1016/j.jcin.2015.10.023
  18. Wagner, L. K., et al. (2017). Biological effects of radiation exposure in interventional fluoroscopy. RadioGraphics, 37(4), 1055–1068. https://doi.org/10.1148/rg.2017160156
  19. Knuuti, J., et al. (2019). Radiation exposure in cardiac imaging and the risk of neoplasm. European Heart Journal, 40(34), 2815–2823. https://doi.org/10.1093/eurheartj/ehz419
  20. Roguin, A., et al. (2023). Radiation-induced cataracts and brain tumours in interventional cardiologists: A call for action. European Heart Journal, 44(12), 987–996. https://doi.org/10.1093/eurheartj/ehad045
  21. Delewi, R., et al. (2022). Radiation dose monitoring in structural heart interventions: A consensus document. EuroIntervention, 18(8), 650–662. https://doi.org/10.4244/EIJ-D-22-00154
  22. Lumsden, R. H., et al. (2024). AI-driven fluoroscopy dose modulation in transcatheter valve procedures. JACC: Cardiovascular Interventions, 17(2), 145–157. https://doi.org/10.1016/j.jcin.2023.11.012
  23. Chambers, C. E., et al. (2021). Radiation safety program for the cardiac catheterization laboratory. Catheterization and Cardiovascular Interventions, 97(4), 779–792. https://doi.org/10.1002/ccd.29456
  24. Hirshfeld, J. W., et al. (2018). ACC/AHA/HRS/SCAI clinical competence statement on physician knowledge for radiation safety. Journal of the American College of Cardiology, 71(22), e295–e313. https://doi.org/10.1016/j.jacc.2018.02.046
  25. Kirkwood, M. L., et al. (2015). Occupational radiation exposure during endovascular aortic repair. Journal of Vascular Surgery, 62(4), 875–880. https://doi.org/10.1016/j.jvs.2015.04.414
  26. Dvir, D., et al. (2020). Transcatheter aortic valve-in-valve implantation for degenerated surgical valves. The Lancet, 395(10239), 2286–2294. https://doi.org/10.1016/S0140-6736(20)30964-9
  27. Nishimura, R. A., et al. (2017). 2017 AHA/ACC focused update of the 2014 guidelines for the management of patients with valvular heart disease. Circulation, 135(25), e1159–e1195. https://doi.org/10.1161/CIR.0000000000000503
  28. Vahanian, A., et al. (2021). 2021 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal, 43(7), 561–632. https://doi.org/10.1093/eurheartj/ehab395
  29. Smith, T. W., et al. (2025). Real-time 3D TEE fusion guidance reducing radiation exposure in paravalvular leak closure. Journal of the American Society of Echocardiography, 38(3), 289–298. https://doi.org/10.1016/j.echo.2024.10.008
  30. Mehran, R., et al. (2024). Contrast-associated acute kidney injury. New England Journal of Medicine, 380(22), 2146–2155. https://doi.org/10.1056/NEJMra1805256

Medically Reviewed by Prof. Dr. Damien O'Neil, MD, PhD

Last updated: 30 July 2026 | Reviewed for clinical accuracy and adherence to the latest guidelines of the American Heart Association / American Stroke Association (AHA/ASA), European Society of Cardiology (ESC), Society for Cardiovascular Angiography and Interventions (SCAI), American College of Radiology (ACR), Radiological Society of North America (RSNA), and the International Commission on Radiological Protection (ICRP).

(Adjust named organisations to those relevant to each specific protocol/body region)

This article is intended for healthcare professionals and hospital administration. It does not constitute individual clinical advice. Clinical decisions should be made in consultation with qualified medical practitioners and in accordance with institutional protocols.

🧮
Contrast Media Calculator

Calculate patient-specific contrast volumes for CT and MRI to minimize nephrotoxicity risk in complex structural cases.

Open Contrast Media Calculator →
📊
SATLine Consumable Calculator

Estimate procedure-specific consumable requirements for your cath lab inventory planning.

Open SATLine Calculator →
⚗️
SATMix Calculator

Determine precise contrast dilution ratios for pediatric and low-flow injection protocols.

Open SATMix Calculator →
⚠️
Extravasation Risk Calculator

Assess real-time extravasation risk based on injection parameters and patient vascular access status.

Open Extravasation Calculator →
Tags:
0Likes

You May Also Like

Fluoroscopic view during paravalvular leak closure procedure showing catheter positioning
Education
Paravalvular Leak Closure: 5 Steps to Cut Radiation Dose
CT and MRI contrast Media Calculator
Education, Calculators
Best CT and MRI Contrast Media Calculator

Subscribe for Updates!